🇺🇸 FDA
Pipeline program

adefovir dipivoxil

ADF104070

Approved small_molecule completed

Quick answer

adefovir dipivoxil for Hepatitis B, Chronic is a Approved program (small_molecule) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).

Program details

Company
GlaxoSmithKline
Indication
Hepatitis B, Chronic
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials